PubAg

Main content area

l- Arginine and allopurinol supplementation attenuates inflammatory mediators in human osteoblasts–osteoarthritis cells

Author:
Li, Jichao, Zhang, Zeng, Huang, Xiaohan
Source:
International journal of biological macromolecules 2018 v.118 pp. 716-721
ISSN:
0141-8130
Subject:
allopurinol, antioxidants, arginine, catalase, cell viability, glutathione, glutathione peroxidase, inflammation, interleukin-1beta, interleukin-6, lipid peroxidation, messenger RNA, osteoarthritis, protein synthesis, superoxide dismutase, synergism, therapeutics, transcription factor NF-kappa B, tumor necrosis factor-alpha
Abstract:
This study investigated the synergistic effects of l-arginine and allopurinol on antioxidant and inflammatory mediators in human osteoblasts–osteoarthritis (HOb-OA) cells. The cells were treated with allopurinol (50–150 mg/kg bwt) and l-arginine (50–150 mg/kg bwt) for 72 h. Cell viability, catalase, superoxide dismutase (SOD), glutathione peroxidase (Gpx), reduced glutathione (GSH), lipid peroxidation, and the inflammatory markers interleukin 6 (IL-6), interleukin 1β (IL-1β), nuclear factor κB (NF-κB) and tumor necrosis factor alpha (TNF-α) were measured. The combined supplementation with allopurinol and l-arginine increased catalase, SOD, GSH, and Gpx, while it decreased lipid peroxidation, IL-6, IL-1β, and TNF-α. While TNF-α, IL-6, IL-1β, and NF-κB mRNA and protein expression were higher in control HOb-OA cells, the combined supplementation with allopurinol and l-arginine substantially reduced their expression in HOb-OA cells by >40%. In summary, combined supplementation with allopurinol and l-arginine might be very effective in osteoarthritis. A search for therapeutic agents that inhibit inflammation could help to prevent and manage osteoarthritis. However, further studies need to determine the biochemical and molecular mechanisms of these agents in osteoarthritis.
Agid:
6018416